Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
13,838,977
Number of holders
23
Total 13F shares, excl. options
5,612,282
Shares change
-125,586
Total reported value, excl. options
$31,482,391
Value change
-$753,086
Put/Call ratio
206%
Number of buys
7
Number of sells
-13
Price
$5.62

Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q4 2023

32 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q4 2023.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,612,282 shares of 13,838,977 outstanding shares and own 41% of the company stock.
Largest 10 shareholders include Battery Management Corp. (2,421,673 shares), NEA Management Company, LLC (1,713,720 shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (684,578 shares), RENAISSANCE TECHNOLOGIES LLC (124,791 shares), BlackRock Inc. (116,097 shares), VANGUARD GROUP INC (82,837 shares), ESSEX INVESTMENT MANAGEMENT CO LLC (77,200 shares), AMERIPRISE FINANCIAL INC (75,044 shares), GEODE CAPITAL MANAGEMENT, LLC (61,349 shares), and NORTHERN TRUST CORP (44,917 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.